kabutan

RIKEN TECHNOS CORPORATION(4220) Summary

4220
TSE Prime
RIKEN TECHNOS CORPORATION
1,723
JPY
-22
(-1.26%)
Mar 13, 3:30 pm JST
10.80
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
11.3
PBR
1.29
Yield
3.02%
Margin Trading Ratio
3.22
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,708 JPY 10.72 USD
Previous Close Mar 12
1,745 JPY 10.97 USD
High Mar 13, 9:35 am
1,745 JPY 10.96 USD
Low Mar 13, 9:00 am
1,702 JPY 10.68 USD
Volume
81,700
Trading Value
0.14B JPY 0.88M USD
VWAP
1723.18 JPY 10.81 USD
Minimum Trading Value
172,300 JPY 1,080 USD
Market Cap
0.09T JPY 0.56B USD
Number of Trades
259
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
333
1-Year High Jan 30, 2026
1,907
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 26,500 64,300 2.43
Feb 27, 2026 20,000 73,700 3.69
Feb 20, 2026 23,000 75,700 3.29
Feb 13, 2026 22,000 73,400 3.34
Feb 6, 2026 22,500 81,300 3.61
Company Profile
RIKEN TECHNOS CORPORATION is a leading manufacturer of PVC compounds. The company also has a strong presence in decorative films, with its highly transparent films featuring antibacterial properties.
Sector
Chemicals
RIKEN TECHNOS CORPORATION specializes in synthetic resin processing, manufacturing and selling compounds, films, and food packaging materials. The company's operations are divided into four market-based segments, covering Transportation (including automotive, railway, and marine), Daily Life & Healthcare, Electronics, and Building & Construction. RIKEN TECHNOS CORPORATION provides products for a wide range of industries, including functional parts for automobiles, medical and healthcare products, cable materials for information infrastructure, and construction materials. With numerous subsidiaries both domestically and internationally, the company operates on a global scale. RIKEN TECHNOS CORPORATION is particularly focused on establishing a strong presence in the Asian and North American automotive markets, while also concentrating on expanding its high-value-added products in the medical field.